Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

Maria Gabriella Ferrandina, Silvio Danese, Giorgia Mangili, Raffaella Cioffi, Saverio Danese, Luigi Frigerio, Gennaro Cormio, Emanuela Rabaiotti, Giovanna Scarfone, Angiolo Gadducci, Alice Bergamini, Carmela Pisano, Massimo Candiani

Research output: Contribution to journal › Article

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study'. Together they form a unique fingerprint.

Medicine & Life Sciences